drugset / Trial / NCT00976131
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
RandomizedCrossoverTriple-blindSupportive care
Summary
This research study hopes to examine the effects of Coenzyme Q10 on doxorubicin (Adriamycin) metabolism during breast cancer treatment.
Timeline
- Start
- 2009-09
- Primary completion
- 2012-09-30
- Completion
- 2021-01-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme Q10 | Other / unclassified | 300 mg | Oral |
| Subject | Coenzyme Q10 | Other / unclassified | 600 mg | Oral |
| Subject | Coenzyme Q10 | Other / unclassified | 1200 mg | Oral |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |